Metabolomics Study Reveals Differences Between Diabetic And Non‐diabetic Patients With Cataract

Discussion in 'Eyes, Ears, Nose and Headaches/Migraines' started by Tristan Loscha, Aug 27, 2020.

  1. Tristan Loscha

    Tristan Loscha Member

    Joined:
    Dec 18, 2018
    Messages:
    2,062
    Gender:
    Male
    An exploratory LC‐MS‐based metabolomics study reveals differences in aqueous humor composition between diabetic and non‐diabetic patients with cataract - PubAg


    An exploratory LC‐MS‐based metabolomics study reveals differences in aqueous humor composition between diabetic and non‐diabetic patients with cataract

    Author:
    Pietrowska, Karolina, Dmuchowska, Diana Anna, Krasnicki, Pawel, Bujalska, Aleksandra, Samczuk, Paulina, Parfieniuk, Ewa, Kowalczyk, Tomasz, Wojnar, Malgorzata, Mariak, Zofia, Kretowski, Adam, Ciborowski, Michal
    Source:
    Electrophoresis 2018 v.39 no.9-10 pp. 1233-1240
    ISSN:
    0173-0835
    Subject:
    amino acid metabolism, antioxidants, blindness, cataract, disease occurrence, electrophoresis, epidemiological studies, eyes, glycosylation, metabolomics, metformin, nicotinamide, nutrients, oxidative stress, patients, people, surgery, taurine, uric acid, xanthine
    Abstract:
    Cataract is the leading cause of blindness worldwide. Epidemiological studies revealed up to a fivefold increased prevalence of cataracts in diabetic subjects. Metabolomics is nowadays frequently implemented to understand pathophysiological processes responsible for disease occurrence and progression. It has also been used recently to study the metabolic composition of aqueous humor (AH). AH is a transparent fluid which fills the anterior and posterior chambers of the eye. It supplies nutrients and removes metabolic waste from avascular tissues in the eye. The aim of this study was to use metabolomics to compare the AH of diabetic and non‐diabetic patients undergoing cataract surgery. Several antioxidants (methyltetrahydrofolic acid, taurine, niacinamide, xanthine, and uric acid) were found decreased (−22 to −61%, p‐value 0.05–0.003) in AH of diabetics. Also amino acids (AA) and derivatives were found decreased (−21 to −36%, p‐value 0.05–0.01) while glycosylated AA increased (+75–98%, p‐value 0.03–0.009) in this group of patients. Metformin was detected in AH of people taking this drug. To our knowledge, this is the first metabolomics study aiming to assess differences in AH composition between diabetic and non‐diabetic patients with cataract. An increased oxidative stress and perturbations in amino acid metabolism in AH may be responsible for earlier cataract onset in diabetic patients.
     

    Attached Files:

Loading...